OPTICAL COHERENCE TOMOGRAPHY FEATURES RELEVANT TO NEOVASCULAR AGE-RELATED MACULAR DEGENERATION MANAGEMENT AND NONNEOVASCULAR AGE-RELATED MACULAR DEGENERATION PROGRESSION: CLINICOPATHOLOGIC CORRELATION

Retin Cases Brief Rep. 2023 Jun 1;17(4S):S41-S46. doi: 10.1097/ICB.0000000000001356.

Abstract

Purpose: Clinicopathologic correlation of two optical coherence tomography (OCT) features in neovascular age-related macular degeneration.

Methods: Case report, clinicopathologic correlation.

Results: A patient in her 90s was diagnosed with Type 3 macular neovascularization secondary to age-related macular degeneration in the index right eye and underwent intravitreal antivascular endothelial growth factor treatment for 5 years. A double-layer sign on in vivo OCT was correlated to calcified drusen on histology. Furthermore, hyperfluorescence on fluorescein angiography corresponded on histology to choroidal hypertransmission on OCT and retinal pigment epithelium atrophy above calcified drusen.

Conclusion: A double-layer sign on OCT can represent nonneovascular subretinal pigment epithelium material including wide and flat calcific nodules. Furthermore, hyperfluorescence on FA, among different origins, can be due to a window defect corresponding to retinal pigment epithelium atrophy, which can be confirmed with OCT. Clinicopathological correlation using high-resolution histology can demonstrate the fine details available to clinical decision making through currently available in vivo OCT imaging.

Publication types

  • Case Reports

MeSH terms

  • Atrophy
  • Child, Preschool
  • Choroid
  • Choroidal Neovascularization* / complications
  • Choroidal Neovascularization* / diagnosis
  • Choroidal Neovascularization* / drug therapy
  • Female
  • Fluorescein Angiography / methods
  • Humans
  • Macular Degeneration* / complications
  • Macular Degeneration* / diagnosis
  • Retrospective Studies
  • Tomography, Optical Coherence / methods
  • Wet Macular Degeneration* / complications
  • Wet Macular Degeneration* / diagnosis
  • Wet Macular Degeneration* / drug therapy